Navigation Links
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
Date:8/1/2011

SAN DIEGO, Aug. 1, 2011 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it will report second quarter 2011 financial results after the NASDAQ Global Select Market closes on Tuesday, August 9, 2011. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, will host a conference call and webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the financial results for the second quarter 2011 and to provide a business and financial update.

The conference call may be accessed by dialing 877.643.7155 for domestic callers and 914.495.8552 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals' Second Quarter 2011 Financial Results Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena PharmaceuticalsArena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, an important class of validated drug targets, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate is intended for weight management.

Arena Pharmaceuticals® and Arena® are registered service marks of the company.

Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the therapeutic indication o
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
2. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
3. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
4. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
5. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
6. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
7. Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
9. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
10. Arena Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
11. Arena and Eisai Complete End-of-Review Meeting with FDA for Lorcaserin New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 The Lupus Foundation of ... LLY ) today released results from UNVEIL: understanding the ... on the lupus journey and the challenges not only ... caregivers. The UNVEIL study, which involved over 1,000 people ... lupus has on all aspects of life including family, ...
(Date:9/16/2014)... Sept. 16, 2014 Imprimis Pharmaceuticals, Inc. (Nasdaq: ... to delivering high quality and novel medicines to physicians ... Executive Officer Mark Baum will be a ... Select Conference in New York City.  Mr. Baum will ... Dropless™ campaign in ophthalmology. The presentation is scheduled for ...
(Date:9/16/2014)... -- Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage company developing ... today that it has entered into an agreement with ... of animal studies for levorphanol, the active ingredient of ... levorphanol.  Gavril Pasternak, MD, PhD, of MSKCC is the ... Pasternak said, "Levorphanol is a unique opioid analgesic that ...
Breaking Medicine Technology:"UNVEIL" Survey Reveals a Life Interrupted by Lupus 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 3"UNVEIL" Survey Reveals a Life Interrupted by Lupus 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 5Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3
... WORTH, Texas, March 22, 2012  The Board of Directors of ... innovator in advanced wound care solutions, announced today that Robert ... of the Company.  In addition, Scott A. Haire has resigned ... Executive Officer of the Company, and Deborah Jenkins Hutchinson has ...
... 22, 2012  Argon Medical Devices, Inc. announced today ... catheter, licensed from Rex Medical, LP, designed to ... treatments. "UltraStream provides clinicians with an ... life for their patients," commented George Leondis, President ...
Cached Medicine Technology:Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 2Wound Management Technologies Names Robert Lutz, Jr. as New CEO; Buys Back North American Distribution Rights for CellerateRX® Powder 3Argon Medical Devices Announces The Launch of a Unique New Chronic Hemodialysis Catheter 2
(Date:9/16/2014)... As part of Child Passenger Safety Week, which ... Amica Insurance is reminding parents and caregivers ... in the car. , According to a 2012 ... (NHTSA), 20 percent of drivers of child passengers admitted ... child restraints. However, 90 percent of those same drivers ...
(Date:9/16/2014)... PA (PRWEB) September 16, 2014 Former ... well today after undergoing successful heart transplantation surgery at ... Mr. Tekulve, who spent most of his 16-year baseball ... team as a commentator for Root Sports Pittsburgh, was ... transplant surgeon, Stephen Bailey, MD, surgical director of AGH’s ...
(Date:9/16/2014)... everyday, but that doesn,t mean the findings are put ... the neonatal mortality rate is 10 times higher than ... applying an inexpensive topical solution of chlorhexidine to cleanse ... by 24 percent, many Indian parents did not receive ... that we don,t have solutions to solve major societal ...
(Date:9/16/2014)... 2014 A team of researchers at Boston University ... new model to study the motion patterns of bacteria ... relate to communication within a bacterial colony. , The ... bacteria to a microcantilever a microscopic beam anchored ... thus coupling its motion to that of the bacteria. ...
(Date:9/16/2014)... 15, 2014A prospective study that compared patient-reported outcomes ... bone metastases demonstrates that single fraction radiation therapy ... radiation therapy (MFRT) when pain, function and quality ... today at the American Society for Radiation Oncology,s ... that improvements in patients, pain, function and degree ...
Breaking Medicine News(10 mins):Health News:Amica Offers Tips During Child Passenger Safety Week 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Pairing social networks with social motives to close the science gap 2Health News:Pairing social networks with social motives to close the science gap 3Health News:And so they beat on, flagella against the cantilever 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4
... rest of nation, , , TUESDAY, Feb. 10 (HealthDay News) -- A ... pain has more than doubled in that state since the early ... in the country as a whole. , "We were actually ... professor of medicine at the University of North Carolina and the ...
... of Americans age 65 and older have prescription drug coverage ... according to a University of Michigan analysis. And poor seniors ... , The analysis compares drug coverage among a nationally ... both in 2004 and after the Medicare Part D prescription ...
... National Leaders in the Effort to Improve Long-Term Care ... SCAN Foundation announced today that two of America,s leading ... for the elderly, Jennie Chin Hansen, R.N., ... named to The SCAN Foundation board of directors.Bruce Chernof, ...
... in Barry Willer,s office at the University at Buffalo was ... a relatively mild traumatic brain injury, and he was doing ... best efforts, the man,s wife described him to friends as ... Willer, UB professor of psychiatry and a specialist in traumatic ...
... Government contract; $28.5 million in contract year one- ... drives revenue for first half- Earnings per share ... Strong balance sheet with $2.1 million in cash, ... Feb. 10 Sharps Compliance Corp. (OTC Bulletin ...
... The Animal Research Minute is a daily report of ... Feb. 10 The Foundation for Biomedical Research (FBR) ... radio broadcast, The Animal Research Minute, nationally after experiencing ... Minute is an educational report of the day,s medical ...
Cached Medicine News:Health News:Chronic Low Back Pain Is on the Rise 2Health News:Chronic Low Back Pain Is on the Rise 3Health News:Most seniors have drug coverage, study shows 2Health News:The SCAN Foundation Names New Members to Its Board 2Health News:The SCAN Foundation Names New Members to Its Board 3Health News:Brain-injured patients can relearn emotions 2Health News:Brain-injured patients can relearn emotions 3Health News:Brain-injured patients can relearn emotions 4Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 2Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 3Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 4Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 5Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 6Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 7Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 8Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 9Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 10Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 11Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 12Health News:Sharps Compliance Corp. Reports Second Quarter Fiscal 2009 Results 13Health News:Foundation for Biomedical Research Announces National Distribution of Daily Radio Broadcast 2
... ACS allows visualization of virtually the ... essentially coaxial positioning of the lens on ... detachment surgery, repairing giant retinal tears, diagnosing ... examining the peripheral retina in a vitreous ...
... somewhat higher magnification and increased ... best suited for detailed visualization ... Central Retinal is ideal for ... membrane peeling in proliferative vitreoretinopathy ...
... MiniQuad allows visualization of virtually the ... with essentially coaxial positioning of the ... excellent for retinal detachment surgery, repairing ... anterior proliferative vitreoretinopathy and for examining ...
... Lens enhances iridectomy procedures by providing ... conventional iridectomy lens designs) with exceptional ... this lens has been increased from ... The MagPlus comes standard with LaserWindow ...
Medicine Products: